Actualités Bearclaw Capital Corp - BRL | Actions TSX Venture Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Bearclaw Capital Announces Resignation of Director

VANCOUVER, British Columbia, May 19, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. ("Bearclaw" or the...

Bearclaw Capital Announces New Chief Financial Officer and Director

VANCOUVER, British Columbia, April 22, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the...

Bearclaw Capital Announces Private Placement

VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the...

Bearclaw Capital Announces Private Placement

VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (NEX:BRL.H) is pleased to...

Bearclaw Capital Announces Effective Date of Share Consolidation and Amendment to Authorized Capital

VANCOUVER, British Columbia, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (TSX Venture Exchange:...

Bearclaw Capital Corp. Announces Mailing of Annual Meeting Material

VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (TSX Venture Exchange: BRL.H...

Bearclaw Capital Corp. to Transfer to NEX Exchange

VANCOUVER, British Columbia, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (TSX-V: BRL.H) (the “Company”) announces that effective...

Prism Resources Inc. Enters Into Agreement in Respect of the Sale of a 7.5% Net Profits Interest to AuRico Metals

VANCOUVER, B.C., July 10, 2017 (GLOBE NEWSWIRE) -- Prism Resources Inc. (TSX.V:PRS) (the “Company”) announces that it has entered into an...

Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

MONTVALE, N.J., Nov. 26 /PRNewswire/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has...

Barr Pharmaceuticals, Inc. Executive Bios

MONTVALE, N.J., March 28 /PRNewswire/ -- Christine A. Mundkur, Esq. Chief Executive Officer, Barr Laboratories, Inc. -- In this newly...

Barr and Galen Receive FTC Request for Information Related to Proposed Transactions

Barr and Galen Receive FTC Request for Information Related to Proposed Transactions WOODCLIFF LAKE, N.J. and CRAIGAVON, Northern Ireland, Dec. 23...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bearclaw Capital Corp (BRL)

Outils de qualité professionnelle, pour des investisseurs individuels.

BRL Actualités

Bearclaw Capital Announces Resignation of Director

Bearclaw Capital Announces New Chief Financial Officer and Director

Bearclaw Capital Announces Private Placement

Bearclaw Capital Announces Private Placement

Bearclaw Capital Announces Effective Date of Share Consolidation and Amendment to Authorized Capital

Bearclaw Capital Corp. Announces Mailing of Annual Meeting Material

Bearclaw Capital Corp. to Transfer to NEX Exchange

Prism Resources Inc. Enters Into Agreement in Respect of the Sale of a 7.5% Net Profits Interest to AuRico Metals

Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

Barr Pharmaceuticals, Inc. Executive Bios

Barr and Galen Receive FTC Request for Information Related to Proposed Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bearclaw Capital Corp (BRL) Actualités

Bearclaw Capital Corp (BRL)

Outils de qualité professionnelle, pour des investisseurs individuels.

BRL Actualités

Bearclaw Capital Announces Resignation of Director

Bearclaw Capital Announces New Chief Financial Officer and Director

Bearclaw Capital Announces Private Placement

Bearclaw Capital Announces Private Placement

Bearclaw Capital Announces Effective Date of Share Consolidation and Amendment to Authorized Capital

Bearclaw Capital Corp. Announces Mailing of Annual Meeting Material

Bearclaw Capital Corp. to Transfer to NEX Exchange

Prism Resources Inc. Enters Into Agreement in Respect of the Sale of a 7.5% Net Profits Interest to AuRico Metals

Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

Barr Pharmaceuticals, Inc. Executive Bios

Barr and Galen Receive FTC Request for Information Related to Proposed Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application